In a recent study published in the journal Brain, Behavior, & Immunity - Health, researchers conducted a prospective population survey, functional brain imaging, and a cognitive task performance test ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. About one in five adults with type 1 diabetes reports ...
Symptomatic improvement on therapy for myeloproliferative neoplasms (MPNs) is very much based on the individual. Data does show momelotinib not only improved spleen size and anemia but also improved ...
The existence of Covid-19 and the SARS-CoV-2 virus that causes the disease has been known for less than half a year. And so it stands to reason that the precise pathogenesis hasn’t been fully ...
This novel coronavirus is bizarre for many reasons, making its spread unpredictable and hard to control. One oddity is how easily people can get infected by someone without symptoms. But there’s a ...
Asymptomatic individuals carrying SARS-CoV-2 shed the virus longer than those with COVID-19 symptoms, with other lab findings suggesting the symptomatic patients mounted more robust immune responses, ...
The scientists are still studying the ways the coronavirus spreads, months into the pandemic. And one of the biggest questions is who can spread the virus. Yesterday, a World Health Organization ...
A statistically significant reduction from baseline in Valsalva LVOT gradient was observed with mavacamten vs placebo at week 28. Topline data were announced from a phase 3 trial evaluating mavacamten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results